- Home
- HSDT vs ASMB Comparison
HSDT vs ASMB Comparison
Compare HSDT & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSDT
- ASMB
- Stock Information
- Founded
- HSDT N/A
- ASMB 2005
- Country
- HSDT United States
- ASMB United States
- Employees
- HSDT N/A
- ASMB N/A
- Industry
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ASMB Biotechnology: Pharmaceutical Preparations
- Sector
- HSDT Health Care
- ASMB Health Care
- Exchange
- HSDT Nasdaq
- ASMB Nasdaq
- Market Cap
- HSDT 194.2M
- ASMB 225.9M
- IPO Year
- HSDT N/A
- ASMB 2010
- Fundamental
- Price
- HSDT $3.14
- ASMB $36.88
- Analyst Decision
- HSDT
- ASMB Strong Buy
- Analyst Count
- HSDT 0
- ASMB 6
- Target Price
- HSDT N/A
- ASMB $43.40
- AVG Volume (30 Days)
- HSDT 743.1K
- ASMB 140.5K
- Earning Date
- HSDT 11-18-2025
- ASMB 11-10-2025
- Dividend Yield
- HSDT N/A
- ASMB N/A
- EPS Growth
- HSDT N/A
- ASMB N/A
- EPS
- HSDT N/A
- ASMB N/A
- Revenue
- HSDT $295,000.00
- ASMB $37,191,000.00
- Revenue This Year
- HSDT N/A
- ASMB $14.29
- Revenue Next Year
- HSDT $75.13
- ASMB N/A
- P/E Ratio
- HSDT N/A
- ASMB N/A
- Revenue Growth
- HSDT N/A
- ASMB 31.30
- 52 Week Low
- HSDT $2.83
- ASMB $7.75
- 52 Week High
- HSDT $1,200.00
- ASMB $39.71
- Technical
- Relative Strength Index (RSI)
- HSDT 27.63
- ASMB 72.03
- Support Level
- HSDT $4.33
- ASMB $35.00
- Resistance Level
- HSDT $5.47
- ASMB $39.71
- Average True Range (ATR)
- HSDT 0.54
- ASMB 2.11
- MACD
- HSDT 0.06
- ASMB 0.30
- Stochastic Oscillator
- HSDT 12.93
- ASMB 83.58
About HSDT Helius Medical Technologies Inc. (DE)
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.